Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07012005 · ClinicalTrials.gov registry record · Phase 1
Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls
A Phase 1 study, sponsored by Shionogi.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT07012005 is a Phase 1 study that has completed, run by Shionogi. The registered enrollment target is 14 participants.
The verdict
NCT07012005, a Phase 1 study, has completed, sponsored by Shionogi.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the pharmacokinetics (PK), safety, and tolerability of BPN14770 in participants with severe renal impairment and those with normal renal function.
Interventions
- DRUG BPN14770
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2025-08-25 |
| Est. Completion | 2025-12-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07012005
The ClinicalTrials.gov registry entry for NCT07012005 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shionogi, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BPN14770 is the first listed.
NCT07012005 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07012005 about?
NCT07012005 is a clinical study titled "Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls". The purpose of this study is to assess the pharmacokinetics (PK), safety, and tolerability of BPN14770 in participants with severe renal impairment and those with normal renal function.
What is the current status of trial NCT07012005?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2025-08-25. Estimated completion is 2025-12-15.
What interventions are being tested in trial NCT07012005?
The interventions under investigation include: BPN14770 (DRUG).
Who is sponsoring clinical trial NCT07012005?
This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.